| Hybrid Ortho/Allosteric Ligands for the Adenosine A1 Receptor R Narlawar, JR Lane, M Doddareddy, J Lin, J Brussee, AP IJzerman Journal of medicinal chemistry 53 (8), 3028-3037, 2010 | 115 | 2010 |
| Prospective validation of a comprehensive in silico hERG model and its applications to commercial compound and drug databases MR Doddareddy, EC Klaasse, Shagufta, AP IJzerman, A Bender ChemMedChem 5 (5), 716-729, 2010 | 113 | 2010 |
| Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites S Ghassabian, T Rawling, F Zhou, MR Doddareddy, BN Tattam, DE Hibbs, ... Biochemical pharmacology 84 (2), 215-223, 2012 | 71 | 2012 |
| The enantiomers of syn-2, 3-difluoro-4-aminobutyric acid elicit opposite responses at the GABA C receptor I Yamamoto, MJT Jordan, N Gavande, MR Doddareddy, M Chebib, ... Chemical Communications 48 (6), 829-831, 2012 | 68 | 2012 |
| New serotonin 5-HT6 ligands from common feature pharmacophore hypotheses HJ Kim, MR Doddareddy, H Choo, YS Cho, KT No, WK Park, AN Pae Journal of chemical information and modeling 48 (1), 197-206, 2008 | 65 | 2008 |
| 3D pharmacophore based virtual screening of T-type calcium channel blockers MR Doddareddy, H Choo, YS Cho, H Rhim, HY Koh, JH Lee, SW Jeong, ... Bioorganic & Medicinal Chemistry 15 (2), 1091-1105, 2007 | 59 | 2007 |
| Targeting mitogen-activated protein kinase phosphatase-1 (MKP-1): structure-based design of MKP-1 inhibitors and upregulators MR Doddareddy, T Rawling, AJ Ammit current medicinal chemistry 19, 2012 | 56 | 2012 |
| Hologram quantitative structure activity relationship studies on 5-HT6 antagonists MR Doddareddy, YJ Lee, YS Cho, KI Choi, HY Koh, AN Pae Bioorganic & medicinal chemistry 12 (14), 3815-3824, 2004 | 56 | 2004 |
| CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists MR Doddareddy, YS Cho, HY Koh, AN Pae Bioorganic & medicinal chemistry 12 (15), 3977-3985, 2004 | 54 | 2004 |
| Synthesis and biological evaluation of novel T-type Ca2+ channel blockers HK Jung, MR Doddareddy, JH Cha, H Rhim, YS Cho, HY Koh, BY Jung, ... Bioorganic & medicinal chemistry 12 (15), 3965-3970, 2004 | 47 | 2004 |
| Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers IW Ku, S Cho, MR Doddareddy, MS Jang, G Keum, JH Lee, BY Chung, ... Bioorganic & medicinal chemistry letters 16 (19), 5244-5248, 2006 | 46 | 2006 |
| IKKβ inhibitors identification part I: Homology model assisted structure based virtual screening S Nagarajan, M reddy Doddareddy, H Choo, YS Cho, KS Oh, BH Lee, ... Bioorganic & medicinal chemistry 17 (7), 2759-2766, 2009 | 44 | 2009 |
| In silico renal clearance model using classical Volsurf approach MR Doddareddy, YS Cho, HY Koh, DH Kim, AN Pae Journal of chemical information and modeling 46 (3), 1312-1320, 2006 | 40 | 2006 |
| First pharmacophoric hypothesis for T-type calcium channel blockers MR Doddareddy, HK Jung, JY Lee, YS Lee, YS Cho, HY Koh, AN Pae Bioorganic & medicinal chemistry 12 (7), 1605-1611, 2004 | 39 | 2004 |
| Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells AM Merlot, S Sahni, DJR Lane, AM Fordham, N Pantarat, DE Hibbs, ... Oncotarget 6 (12), 10374, 2015 | 37 | 2015 |
| Design, synthesis, and biological evaluation of 1, 3-dioxoisoindoline-5-carboxamide derivatives as T-type calcium channel blockers HS Kim, Y Kim, MR Doddareddy, SH Seo, H Rhim, J Tae, AN Pae, ... Bioorganic & medicinal chemistry letters 17 (2), 476-481, 2007 | 37 | 2007 |
| A carbocyclic curcumin inhibits proliferation of gram-positive bacteria by targeting FtsZ PW Groundwater, R Narlawar, VWY Liao, A Bhattacharya, S Srivastava, ... Biochemistry 56 (3), 514-524, 2017 | 35 | 2017 |
| Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammation L Munoz, ME Kavanagh, AF Phoa, B Heng, N Dzamko, EJ Chen, ... European Journal of Medicinal Chemistry 95, 29-34, 2015 | 35 | 2015 |
| Lead discovery and optimization of T-type calcium channel blockers JH Park, JK Choi, E Lee, JK Lee, H Rhim, SH Seo, Y Kim, ... Bioorganic & medicinal chemistry 15 (3), 1409-1419, 2007 | 35 | 2007 |
| The development of CNS-active LRRK2 inhibitors using property-directed optimisation ME Kavanagh, MR Doddareddy, M Kassiou Bioorganic & Medicinal Chemistry Letters 23 (13), 3690-3696, 2013 | 34 | 2013 |
Andreas BenderUniversity of Cambridge; Pangea Bio; Universitatea Babeș-Bolyai; UMF ClujPatvirtintas el. paštas cam.ac.uk